SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-079407
Filing Date
2014-11-12
Accepted
2014-11-12 09:05:56
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19701_110q.htm 10-Q 848354
2 EX-31.1 a14-19701_1ex31d1.htm EX-31.1 9229
3 EX-31.2 a14-19701_1ex31d2.htm EX-31.2 9358
4 EX-32.1 a14-19701_1ex32d1.htm EX-32.1 5484
5 EX-32.2 a14-19701_1ex32d2.htm EX-32.2 5488
  Complete submission text file 0001104659-14-079407.txt   3479086

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fate-20140930.xml EX-101.INS 388121
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fate-20140930.xsd EX-101.SCH 24905
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fate-20140930_cal.xml EX-101.CAL 35793
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fate-20140930_def.xml EX-101.DEF 71718
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT fate-20140930_lab.xml EX-101.LAB 277163
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fate-20140930_pre.xml EX-101.PRE 168679
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36076 | Film No.: 141211543
SIC: 2836 Biological Products, (No Diagnostic Substances)